Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome
Antonella Tramutola, Chiara Lanzillotta, Fabio Di Domenico, et al.
Neurobiology of Disease (2020) Vol. 137, pp. 104772-104772
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease
Eugenio Barone, Fabio Di Domenico, Marzia Perluigi, et al.
Free Radical Biology and Medicine (2021) Vol. 176, pp. 16-33
Open Access | Times Cited: 98
Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
Jorge Berlanga‐Acosta, Gerardo Guillén, Nadia Rodríguez-Rodríguez, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 91
Proteomics Study of Peripheral Blood Mononuclear Cells in Down Syndrome Children
Chiara Lanzillotta, Viviana Greco, Diletta Valentini, et al.
Antioxidants (2020) Vol. 9, Iss. 11, pp. 1112-1112
Open Access | Times Cited: 83
The Biomedical Uses of Inositols: A Nutraceutical Approach to Metabolic Dysfunction in Aging and Neurodegenerative Diseases
Antonio J. López-Gambero, Carlos Sanjuan, Pedro Jesús Serrano Castro, et al.
Biomedicines (2020) Vol. 8, Iss. 9, pp. 295-295
Open Access | Times Cited: 77
Brain lipid peroxidation and alzheimer disease: Synergy between the Butterfield and Mattson laboratories
D. Allan Butterfield
Ageing Research Reviews (2020) Vol. 64, pp. 101049-101049
Open Access | Times Cited: 72
Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress
Nicole Rummel, D. Allan Butterfield
Antioxidants and Redox Signaling (2021) Vol. 36, Iss. 16-18, pp. 1289-1305
Open Access | Times Cited: 70
State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer’s Disease
Elizabeth M. Rhea, Manon Leclerc, Hussein N. Yassine, et al.
Aging and Disease (2023)
Open Access | Times Cited: 35
Effects of ketogenic diet on cognitive function of patients with Alzheimer's disease: a systematic review and meta-analysis
Liyang Rong, Yating Peng, Qi Shen, et al.
The journal of nutrition health & aging (2024) Vol. 28, Iss. 8, pp. 100306-100306
Open Access | Times Cited: 9
Review of Associations of Diabetes and Insulin Resistance With Brain Health in Three Harmonised Cohort Studies of Ageing and Dementia
Roshni Biswas, Ana W. Capuano, Rupal I. Mehta, et al.
Diabetes/Metabolism Research and Reviews (2025) Vol. 41, Iss. 1
Open Access | Times Cited: 1
Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions
Mara Dierssen, Marta Fructuoso, Maria Martínez de Lagrán, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 65
Targeting Insulin Resistance to Treat Cognitive Dysfunction
Anit Tyagi, Subbiah Pugazhenthi
Molecular Neurobiology (2021) Vol. 58, Iss. 6, pp. 2672-2691
Open Access | Times Cited: 42
Targeting Alzheimer’s Disease: The Critical Crosstalk between the Liver and Brain
Zhihai Huang, Hung Wen Lin, Quanguang Zhang, et al.
Nutrients (2022) Vol. 14, Iss. 20, pp. 4298-4298
Open Access | Times Cited: 30
The role of insulin/IGF1 signalling in neurodevelopmental and neuropsychiatric disorders – Evidence from human neuronal cell models
János Réthelyi, Katalin Vincze, Dorothea Schall, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 153, pp. 105330-105330
Open Access | Times Cited: 19
Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model
Chiara Lanzillotta, Monika Rataj Baniowska, Francesca Prestia, et al.
Neurobiology of Disease (2024) Vol. 196, pp. 106523-106523
Open Access | Times Cited: 7
Lower GLUT1 and unchanged MCT1 in Alzheimer’s disease cerebrovasculature
Manon Leclerc, Cyntia Tremblay, Philippe Bourassa, et al.
Journal of Cerebral Blood Flow & Metabolism (2024) Vol. 44, Iss. 8, pp. 1417-1432
Open Access | Times Cited: 6
Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: A harmful synergistic path in down syndrome
Chiara Lanzillotta, Antonella Tramutola, Graziella Di Giacomo, et al.
Free Radical Biology and Medicine (2021) Vol. 165, pp. 152-170
Closed Access | Times Cited: 33
Icariin ameliorates memory deficits through regulating brain insulin signaling and glucose transporters in 3×Tg-AD mice
Shaoyu Zhou, Feng Jin, Fei Yan, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 1, pp. 183-183
Open Access | Times Cited: 27
Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer’s Disease-like Neuropathology in a Mouse Model for Down Syndrome
Antonella Tramutola, Simona Lanzillotta, Giuseppe Aceto, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 111-111
Open Access | Times Cited: 15
Brain insulin signaling as a potential mediator of early life adversity effects on physical and mental health
Bonnie Alberry, Patrícia Pelufo Silveira
Neuroscience & Biobehavioral Reviews (2023) Vol. 153, pp. 105350-105350
Open Access | Times Cited: 15
Insulin resistance and bioenergetic manifestations: Targets and approaches in Alzheimer's disease
Vivek Sharma, Thakur Gurjeet Singh
Life Sciences (2020) Vol. 262, pp. 118401-118401
Closed Access | Times Cited: 38
Cellular senescence and premature aging in Down Syndrome
Lianli Peng, Alireza A. Baradar, Julio Aguado, et al.
Mechanisms of Ageing and Development (2023) Vol. 212, pp. 111824-111824
Closed Access | Times Cited: 11
Redox imbalance and metabolic defects in the context of Alzheimer disease
Fabio Di Domenico, Chiara Lanzillotta, Marzia Perluigi
FEBS Letters (2024)
Open Access | Times Cited: 4
Antioxidants in Down Syndrome: From Preclinical Studies to Clinical Trials
Noemí Rueda Revilla, Carmen Martínez‐Cué
Antioxidants (2020) Vol. 9, Iss. 8, pp. 692-692
Open Access | Times Cited: 28
Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal‐derived extracellular vesicles
Marzia Perluigi, Anna Picca, Elita Montanari, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 8, pp. 1498-1510
Open Access | Times Cited: 25
Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules
Chiara Lanzillotta, Fabio Di Domenico
Biomolecules (2021) Vol. 11, Iss. 2, pp. 266-266
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top